Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12607000028404Phase 2Completed
Phase 2, randomised, double-blind trial in sepsis comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Change in serum interleukin-6 level. Started Jul 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12607000028404.